Acute Hepatic Porphyria clinical trials at UCSF

• EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)

  open to eligible people ages 12 years and up

  The purpose of this study is to characterize the natural history and clinical management of Acute Hepatic Porphyria (AHP) patients with recurring attacks.

  San Francisco, California and other locations

• ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)

  Sorry, in progress, not accepting new patients

  The purpose of this study is to evaluate the effect of subcutaneous givosiran (ALN-AS1), compared to placebo, on the rate of porphyria attacks in patients with Acute Hepatic Porphyrias (AHP).

  San Francisco, California and other locations

Last updated: May 8, 2020